维普中文期刊产品整合服务
39篇 您的检索式:作者名="Markart"
    题名 作者 年代 出处 被引量
1Chemical crosslinking of urokinase to pulmonary surfactant protein B for targeting alveolar fibrin显示文摘Ruppert C Markart P Schmidt R 2003Thromb Haemost2003,,89:1
2Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration 显示文摘Schmidt R Markart P Ruppert C 2007Respir Res2007,27,:1
3Interstitial lung disease显示文摘von der Beck D Gunther A Markart P 2011Dtsch Med Wochenschr2011,136,22:1
4Raised protein levels and altered cellular expression of factor Ⅶ activating protease(FSAP) in the lungs of patients with acute re-spiratory distress syndrome (ARDS) 显示文摘Wygrecka M Markart P Fink L 2007Thorax2007,62,:1
5P- ulmonary fibrosis-a therapeutic dilemma 显示文摘GUNTHER A MARKART P EICKELBERG O 2006Med Klin (Munich)2006,101,4:1
6Plasminogen activator inhibitor-1 (PAI-1) is an inhibitor of factor Ⅶ- activating protease in patients with acute respiratory distress syndrome显示文摘Wygrecka M Morty RE Markart P 2007J Biol Chem2007,282,21:1
7Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration显示文摘Schmidt R Markart P Ruppert C 2007Respir Res2007,8,:1
8Compartment and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application显示文摘Wygrecka M Markart P Ruppert C 2004Thromb Haemost2004,92,:1
9Role of coagu- lation and fibrinolysis in lung and renal fibrosis 显示文摘Ruppert C Markart P Wygrecka M 2008Harnostaseologie2008,28,12:1
10Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration显示文摘Schmidt R Markart P Ruppert C 2007Respir Res2007,8,:1
11Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias 显示文摘Markart P Ruppert C Wygrecka M 2007Eur Respir J2007,29,1:1
12Role of coagulation and fibrinolysis in lung and renal fibrosis显示文摘Ruppert C Markart P Wygrecka M 2008Hamostaseologie2008,28,12:1
13Pulmonary fibrosis a therapeutic dilemma显示文摘Gtinther A Markart P Eiekelberg O 2006Med Klin (Munich)2006,101,4:1
14Alveolar Oxidative Stress is Associated with Elevated Levels of Nonenzymatic Low-Molecular-Weight Antioxidants in Patients with Different Forms of Chronic Fibrosing Interstitial Lung Diseases 显示文摘Philipp Markart Thomas Luboeinski Martina Korfei 2009Antioxid Redox Signal2009,11,2:1
15Pulmonary suffactant in pa- tients with Pneumocystis pneumonia and acquired immunodeficiency syndrome 显示文摘Schmidt R Markart P Ruppert C 2006Crit Care Med2006,34,9:1
16Interstitial lung disease 显示文摘yon tier Beck D Gunter A Markart P 2011Dtsch Med Woehenschr2011,136,22:1
17Plasnfinogen activator inhibitor-1 is an inhibitor of factor Vii-activating protease in pa- tients with acute respiratory distress syndrome 显示文摘Wygrecka M Morty RE Markart P 2007J Biol Chem2007,282,21:1
18Obstructive sleep ap- nea,oxidative stress,and cardiovascular disease:evidence from Human studies显示文摘EISELE HJ MARKART P SCHULZ R 2015Oxid Med Cell Longev2015,2015,60:1
19Alveolaroxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases 显示文摘Markart P Luboeinski T Korfei M 2009Antioxid Redox Signal2009,11,2:1
20Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P显示文摘Markart P Faust N Graf T 2004Biochem J2004,380,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费